242 related articles for article (PubMed ID: 12682161)
41. Predicting high vancomycin minimum inhibitory concentration isolate infection among patients with community-onset methicillin-resistant Staphylococcus aureus bacteraemia.
Chen SY; Hsueh PR; Chiang WC; Huang EP; Lin CF; Chang CH; Chen SC; Chen WJ; Chang SC; Lai MS; Chie WC
J Infect; 2014 Sep; 69(3):259-65. PubMed ID: 24797078
[TBL] [Abstract][Full Text] [Related]
42. Growing Resistance to Vancomycin among Methicillin Resistant Staphylococcus Aureus Isolates from Different Clinical Samples.
Pahadi PC; Shrestha UT; Adhikari N; Shah PK; Amatya R
JNMA J Nepal Med Assoc; 2014; 52(196):977-81. PubMed ID: 26982895
[TBL] [Abstract][Full Text] [Related]
43. Population structure and characterisation of Staphylococcus aureus from bacteraemia at multiple hospitals in China: association between antimicrobial resistance, toxin genes and genotypes.
He W; Chen H; Zhao C; Zhang F; Li H; Wang Q; Wang X; Wang H
Int J Antimicrob Agents; 2013 Sep; 42(3):211-9. PubMed ID: 23871455
[TBL] [Abstract][Full Text] [Related]
44. In vivo development of decreased susceptibility to vancomycin in clinical isolates of methicillin-resistant Staphylococcus aureus.
Sugino Y; Iinumab Y; Ichiyama S; Ito Y; Ohkawa S; Nakashima N; Shimokata K; Hasegawa Y
Diagn Microbiol Infect Dis; 2000 Nov; 38(3):159-67. PubMed ID: 11109014
[TBL] [Abstract][Full Text] [Related]
45. More accurate measurement of vancomycin minimum inhibitory concentration indicates poor outcomes in meticillin-resistant Staphylococcus aureus bacteraemia.
Shoji H; Maeda M; Shirakura T; Takuma T; Ugajin K; Fukuchi K; Ishino K; Niki Y
Int J Antimicrob Agents; 2015 Nov; 46(5):532-7. PubMed ID: 26364848
[TBL] [Abstract][Full Text] [Related]
46. Sequence Type 5 (ST5) as a Possible Predictor of Bacterial Persistence in Adult Patients with Methicillin-Resistant Staphylococcus aureus Pneumonia Treated with Vancomycin.
Fan YX; Chen MT; Li NY; Liu XF; Yang MJ; Chen YC; Liang XY; Wu JF; Guo BN; Song SC; Zhu YQ; Zhang FY; Hang JQ; Wu SB; Shen B; Li HY; Wang Q; Luo XM; Chen QG; Zhang HF; Wang RL; Shen LH; Fu FM; Song XL; Zhang J
Microbiol Spectr; 2022 Oct; 10(5):e0134822. PubMed ID: 36094217
[TBL] [Abstract][Full Text] [Related]
47. In vivo development of daptomycin resistance in vancomycin-susceptible methicillin-resistant Staphylococcus aureus severe infections previously treated with glycopeptides.
Capone A; Cafiso V; Campanile F; Parisi G; Mariani B; Petrosillo N; Stefani S
Eur J Clin Microbiol Infect Dis; 2016 Apr; 35(4):625-31. PubMed ID: 26815434
[TBL] [Abstract][Full Text] [Related]
48. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin.
Hiramatsu K; Aritaka N; Hanaki H; Kawasaki S; Hosoda Y; Hori S; Fukuchi Y; Kobayashi I
Lancet; 1997 Dec; 350(9092):1670-3. PubMed ID: 9400512
[TBL] [Abstract][Full Text] [Related]
49. Is there a clinical association of vancomycin MIC creep, agr group II locus, and treatment failure in MRSA bacteremia?
de Sanctis JT; Swami A; Sawarynski K; Gerasymchuk L; Powell K; Robinson-Dunn B; Carpenter CF; Sims MD
Diagn Mol Pathol; 2011 Sep; 20(3):184-8. PubMed ID: 21817905
[TBL] [Abstract][Full Text] [Related]
50. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
Sakoulas G; Moellering RC
Clin Infect Dis; 2008 Jun; 46 Suppl 5():S360-7. PubMed ID: 18462091
[TBL] [Abstract][Full Text] [Related]
51. Rising incidence of Staphylococcus aureus with reduced susceptibility to vancomycin and susceptibility to antibiotics: a global analysis 2004-2009.
Hawser SP; Bouchillon SK; Hoban DJ; Dowzicky M; Babinchak T
Int J Antimicrob Agents; 2011 Mar; 37(3):219-24. PubMed ID: 21239146
[TBL] [Abstract][Full Text] [Related]
52. Epidemiology and outcomes of community-associated methicillin-resistant Staphylococcus aureus infection.
Davis SL; Perri MB; Donabedian SM; Manierski C; Singh A; Vager D; Haque NZ; Speirs K; Muder RR; Robinson-Dunn B; Hayden MK; Zervos MJ
J Clin Microbiol; 2007 Jun; 45(6):1705-11. PubMed ID: 17392441
[TBL] [Abstract][Full Text] [Related]
53. Protracted and recurrent methicillin-resistant Staphylococcus aureus bacteremia despite defervescence with vancomycin therapy.
Khatib R; Riederer KM; Held M; Aljundi H
Scand J Infect Dis; 1995; 27(5):529-32. PubMed ID: 8588150
[TBL] [Abstract][Full Text] [Related]
54. Vancomycin MICs did not creep in Staphylococcus aureus isolates from 2002 to 2006 in a setting with low vancomycin usage.
Alós JI; García-Cañas A; García-Hierro P; Rodríguez-Salvanés F
J Antimicrob Chemother; 2008 Oct; 62(4):773-5. PubMed ID: 18552338
[TBL] [Abstract][Full Text] [Related]
55. Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia.
Khatib R; Saeed S; Sharma M; Riederer K; Fakih MG; Johnson LB
Eur J Clin Microbiol Infect Dis; 2006 Mar; 25(3):181-5. PubMed ID: 16505987
[TBL] [Abstract][Full Text] [Related]
56. Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan.
Naimi HM; Rasekh H; Noori AZ; Bahaduri MA
BMC Infect Dis; 2017 Nov; 17(1):737. PubMed ID: 29187146
[TBL] [Abstract][Full Text] [Related]
57. Nationwide survey shows that methicillin-resistant Staphylococcus aureus strains heterogeneously and intermediately resistant to vancomycin are not disseminated throughout Japanese hospitals.
Ike Y; Arakawa Y; Ma X; Tatewaki K; Nagasawa M; Tomita H; Tanimoto K; Fujimoto S
J Clin Microbiol; 2001 Dec; 39(12):4445-51. PubMed ID: 11724859
[TBL] [Abstract][Full Text] [Related]
58. High vancomycin minimum inhibitory concentrations with heteroresistant vancomycin-intermediate Staphylococcus aureus in meticillin-resistant S. aureus bacteraemia patients.
Wang JL; Lai CH; Lin HH; Chen WF; Shih YC; Hung CH
Int J Antimicrob Agents; 2013 Nov; 42(5):390-4. PubMed ID: 24041465
[TBL] [Abstract][Full Text] [Related]
59. Comparative activity of oritavancin against meticillin-resistant Staphylococcus aureus (MRSA) bloodstream isolates from Geneva University Hospital.
Vaudaux P; Huggler E; Arhin FF; Moeck G; Renzoni A; Lew DP
Int J Antimicrob Agents; 2009 Dec; 34(6):540-3. PubMed ID: 19744838
[TBL] [Abstract][Full Text] [Related]
60. Emergence of multidrug-resistant sequence type 45 strains among mecA-positive borderline oxacillin-resistant Staphylococcus aureus causing bacteraemia in a medical centre in Taiwan.
Huang YT; Liao CH; Chen SY; Hsu HS; Teng LJ; Hsueh PR
Int J Antimicrob Agents; 2018 Jul; 52(1):70-75. PubMed ID: 29505885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
